世界卫生组织(WHO)于2020年3月11日宣布COVID-19为大流行,因为其广泛传播和感染率。在武汉发现了这种独特的严重疾病,中国,自2019年12月以来,迅速传播到世界各地。来自草药和药用蘑菇的天然化学物质为新型抗病毒药物的开发提供了重要的资源。许多天然药物已被证明对多种病毒株具有抗病毒特性,如冠状病毒和单纯疱疹病毒(HSV)。.在这项研究中,对不同COVID疾病的成功饮食治疗方法与蘑菇产品在治疗中的潜力进行了比较。在谷歌学者,科学直接,PubMed,还有Scopus,搜索像COVID这样的关键词,COVID-19,SARS,MERS,蘑菇,和他们的化合物被利用。在这篇文献综述中,我们讨论了流行的蘑菇,例如姬松茸,姬松茸,冬虫夏草(Berk。)萨克。,灵芝(柯蒂斯。)P.岩溶。,灰树花(迪克斯。)灰色,猴头菇(公牛。)Pers。,褐藻(拱门。前佩尔斯。)皮尔。,香菇(Berk。)佩格勒,平菇(Jacq。)P.库姆。,PoriacocosF.A.Wolf,和杂色Trametes(L.)劳埃德。,.β-葡聚糖的改变形式似乎对病毒复制抑制有良好的影响,并可能用于未来的研究。然而,结果似乎是萜类化合物,凝集素,糖蛋白,香菇多糖,半乳甘露聚糖,蘑菇中的多糖是有前途的预防或治疗COVID-19的药物。
The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020, because of its widespread transmission and infection rates. The unique severe disease was found in Wuhan, China, since December 2019, and swiftly spread throughout the world. Natural chemicals derived from herbal medicines and medicinal
mushrooms provide a significant resource for the development of novel antiviral drugs. Many natural drugs have been proven to have antiviral properties against a variety of virus strains, such as the coronavirus and the herpes simplex virus (HSV).. In this research, successful dietary treatments for different COVID illnesses were compared to potential of mushroom products in its therapy. In Google Scholar, Science Direct, PubMed, and Scopus, search keywords like COVID, COVID-19, SARS, MERS,
mushrooms, and their compounds were utilized. In this
review of the literature we foucsed popular
mushrooms such as Agaricus subrufescens Peck, Agaricus blazei Murill, Cordyceps sinensis (Berk.) Sacc., Ganoderma lucidum (Curtis.) P. Karst., Grifola frondosa (Dicks.) Gray, Hericium erinaceus (Bull.) Pers., Inonotus obliquus (Arch. Ex Pers.) Pilát., Lentinula edodes (Berk.) Pegler, Pleurotus ostreatus (Jacq.) P. Kumm., Poria cocos F.A. Wolf, and Trametes versicolor (L.) Lloyd.,. Changed forms of β-Glucan seem to have a good impact on viral replication suppression and might be used in future studies. However, the results seems terpenoids, lectins, glycoproteins, lentinan, galactomannan, and polysaccharides from
mushrooms are promising prophylactic or therapeutic agents against COVID-19.